PAI-1

plasminogen activator inhibitor type 1(English)

  • has become recognized as a central molecule linking pathogenesis and progression of thrombotic vascular events including stroke. As a main endogenous inhibitor of tPA, PAI-1 might be related to reperfusion efficacy and hemorrhagic risk of tPA thrombolytic therapy
  • PAI
  • Cerebrovascular event
  • https://doi.org…EAHA.111.622217